Skip to main content

Table 1 Comparison of general information between the treated group and the control group

From: Efficacy of rTMS for poststroke epilepsy and its effects on patients’ cognitive function and depressive status

 

Treated

Control

χ2/F

P

Gender (M/F)

31/22

34/34

0.864

0.353

Age

67.68 ± 13.48

13.47758

13.47758

64.56 ± 12.81

1.688

0.196

NIHSS score

7.17 ± 9.00

4.79 ± 5.52

3.197

0.076

Hypertension (N/Y)

9/44

13/55

0.091

0.762

Diabetes(N/Y)

38/15

49/19

0.002

0.965

Atrial fibrillation (N/Y)

52/1

62/6

2.629

0.105

Hyperlipidemia (N/Y)

41/12

48/20

0.702

0.402

Coronary heart disease (N/Y)

44/9

57/11

0.012

0.906

Family history of epilepsy (N/Y)

51/2

65/3

0.031

0.861

Smoking History (N/Y)

43/10

48/20

1.776

0.183

Drinking History (N/Y)

48/5

61/7

0.025

0.875